Hendrik Ruge

Showing 1-3 of 3 articles

Interventions for valvular disease

Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study

Manoharan G, Grube E, Van Mieghem N, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh J, Fan Y, Windecker S

November 20, 2020 | 10.4244/EIJ-D-20-00279

Interventions for valvular disease

Clinical experience with a novel large bore vascular closure device after transfemoral transcatheter aortic valve replacement

Ruge H, Erlebach M, Mayr P, Bleiziffer S, Lange R

June 25, 2020 | 10.4244/EIJ-D-19-00523

Interventions for valvular disease

Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices

Deutsch M-A, Erlebach M, Burri M, Hapfelmeier A, Witt OG, Ziegelmueller JA, Wottke M, Ruge H, Krane M, Piazza N, Bleiziffer S, Lange R

May 20, 2018 | 10.4244/EIJ-D-17-00603

1

Latest news

200 Issues at the Heart of Interventional Cardiology

January 28, 2022

Simulation-based planning of transcatheter left atrial appendage occlusion

FREE ARTICLE - Nils Perrin et al

January 26, 2022

Features of atherosclerosis in patients with angina and no obstructive coronary artery disease

FREE ARTICLE - Dario Pellegrini et al

January 27, 2022

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

2021 ESC/EACTS Guidelines for the management of valvular heart disease

FREE ARTICLE - Alec Vahanian et al.

December 22, 2021

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

Valvular disease